Search research articles
Contact Us
Filters
Showing results (1-10 of 35) with videos related to
Page
of 4
Sort By:
Future Oncology (London, England)
|
June 4, 2008
Future directions in the management of epithelial ovarian cancer
Sarah Blagden, Hani Gabra
Biomolecules
|
October 27, 2015
The La-Related Proteins, a Family with Connections to Cancer
Chara Stavraka, Sarah Blagden
Cancers
|
April 12, 2022
Inhibiting the Priming for Cancer in Li-Fraumeni Syndrome
Pan Pantziarka, Sarah Blagden
Current Opinion in Oncology
|
June 26, 2009
Promising molecular targets in ovarian cancer
Sarah Blagden, Hani Gabra
Journal of Public Health (Oxford, England)
|
February 1, 2018
Meningococcal vaccination in primary care amongst adolescents in North West England: an ecological study investigating associations with general practice characteristics
Sarah Blagden, Daniel Hungerford, Mark Limmer
Wiley Interdisciplinary Reviews. RNA
|
August 2, 2017
Ancient and modern: hints of a core post-transcriptional network driving chemotherapy resistance in ovarian cancer
Sarah Blagden, Mai Abdel Mouti, James Chettle
BMC Cancer
|
July 13, 2011
Sustained platelet-sparing effect of weekly low dose paclitaxel allows effective, tolerable delivery of extended dose dense weekly carboplatin in platinum resistant/refractory epithelial ovarian cancer
Rohini Sharma, Janet Graham, Sarah Blagden, et al.
BMJ Case Reports
|
April 26, 2013
Tumour lysis syndrome in a patient with intravascular spread from a recurrent epithelial ovarian cancer
Michelle Camarata, Roger Davies, Sue Copley, et al.
Plos One
|
August 3, 2017
Uptake of a new meningitis vaccination programme amongst first-year undergraduate students in the United Kingdom: A cross-sectional study
Sarah Blagden, Daniel Seddon, Daniel Hungerford, et al.
Journal of Public Health (Oxford, England)
|
January 10, 2021
NICE public health guidance update
Sarah Blagden, Catrin Austin, Roberta Richey, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 35) with videos related to
Sort By:
Page
of 4
Future Oncology (London, England)
|
June 4, 2008
Future directions in the management of epithelial ovarian cancer
Sarah Blagden, Hani Gabra
Biomolecules
|
October 27, 2015
The La-Related Proteins, a Family with Connections to Cancer
Chara Stavraka, Sarah Blagden
Cancers
|
April 12, 2022
Inhibiting the Priming for Cancer in Li-Fraumeni Syndrome
Pan Pantziarka, Sarah Blagden
Current Opinion in Oncology
|
June 26, 2009
Promising molecular targets in ovarian cancer
Sarah Blagden, Hani Gabra
Journal of Public Health (Oxford, England)
|
February 1, 2018
Meningococcal vaccination in primary care amongst adolescents in North West England: an ecological study investigating associations with general practice characteristics
Sarah Blagden, Daniel Hungerford, Mark Limmer
Wiley Interdisciplinary Reviews. RNA
|
August 2, 2017
Ancient and modern: hints of a core post-transcriptional network driving chemotherapy resistance in ovarian cancer
Sarah Blagden, Mai Abdel Mouti, James Chettle
BMC Cancer
|
July 13, 2011
Sustained platelet-sparing effect of weekly low dose paclitaxel allows effective, tolerable delivery of extended dose dense weekly carboplatin in platinum resistant/refractory epithelial ovarian cancer
Rohini Sharma, Janet Graham, Sarah Blagden, et al.
BMJ Case Reports
|
April 26, 2013
Tumour lysis syndrome in a patient with intravascular spread from a recurrent epithelial ovarian cancer
Michelle Camarata, Roger Davies, Sue Copley, et al.
Plos One
|
August 3, 2017
Uptake of a new meningitis vaccination programme amongst first-year undergraduate students in the United Kingdom: A cross-sectional study
Sarah Blagden, Daniel Seddon, Daniel Hungerford, et al.
Journal of Public Health (Oxford, England)
|
January 10, 2021
NICE public health guidance update
Sarah Blagden, Catrin Austin, Roberta Richey, et al.
Page
of 4